T he last decade of research in critical care has led to few novel effective drugs or devices; however, multiple studies have shown that nurse and respiratory therapist-directed treatment protocols focused on weaning, sedation, patient positioning, and glucose control can have a significant effect on patient outcome (1) (2) (3) (4) . Unfortunately, an extensive body of research shows that clinical practice frequently deviates from recommended practice (5) . Evidence on barriers to implementing change specific to the intensive care unit (ICU) is in its infancy, and understanding the barriers and facilitators to change is essential to implementing effective practice (6, 7) . A recent review of barriers to implementing effective practice found no studies that specifically explored the barriers to implementing best practices in critical care (8) .
Recently, two clinical trials have shown that lung-protective ventilation strategies that limit tidal volumes, lower airway pressures, permit hypercapnia, and allow mild acidosis are associated with a reduction in mortality rate in acute respiratory distress syndrome (ARDS) (9, 10) . However, recent data comparing practice before and after release of clinical trial results show that ventilator management in patients with acute lung injury, even at academic sites, has changed very little since publication of the ARDS Network (11) . Although the physiologic principles of lung-protective ventilation have been known for some time, mechanically ventilated patients receive similar tidal volumes and positive end-expiratory pressure levels regardless of the etiology of their respiratory failure (12) . Several aspects of lung-protective ventilation make the study of clinician barriers to its use important. Ventilator management of critically ill patients is a collaborative effort involving physicians, nurses, and, in some countries, respiratory therapists. Changing clinical practice in ventilator management will involve identifying barriers to changing behavior in all of the relevant clinicians, not just physicians (8) . For medical treatments involving new drugs or devices, there is a fiscal incentive for the developer to identify and overcome barriers to their use. This is not the case with lungprotective ventilation for acute lung injury (ALI)/ARDS, which does not require a new drug or device. Finally, lungprotective ventilation requires clinicians to reconsider many of the respiratory rate, tidal volume, and arterial blood gas goals they were trained to use in managing patients on mechanical ventilation. To address these issues, we performed a survey of experienced ICU nurses and respiratory therapists to identify the barriers that they encountered when using lung-protective ventilation.
METHODS
Study Design and Population. The study design was a survey. The sample was identified through purposive sampling of the research coordinators at all ten of the National Institutes of Health-sponsored ARDS Network sites that performed the clinical trial showing efficacy of the ventilatory strategy (13) . The purpose of the sampling frame was to identify clinicians experienced with lung-protective ventilation. This was accomplished by asking the research coordinators at each site to identify at least three ICU nurses and at least three respiratory therapists with the most experience using lung-protective ventilation tested in the ARDS Network clinical trial; research coordinators were specifically asked to identify respondents with experience using this technique outside of the clinical trial. The rationale for sampling these sites and these respondents was based on our desire to identify clinicians with experience using lung-protective ventilation. Before the results of this study, clinical experience with lung-protective ventilation strategies would be erratic and we believed that asking clinicians about barriers to providing a therapy with which they had little experience would not be helpful. Surveys were distributed and either collected by the on-site coordinator or faxed directly to the investigators. Respondents indicated their site and their profession, but the survey was otherwise anonymous to the investigators. This project was approved by the ARDS Network and the University of Washington Institutional Review Board.
Survey Instrument. An initial draft of the survey was piloted with three physicians, two ICU nurses, and two respiratory therapists at Harborview Medical Center. Based on their feedback, the instrument was revised and organized into five questions on barriers to initiating lung-protective ventilation and five questions on barriers to staying on lungprotective ventilation. These ten questions were coded on a scale from 1 (very important barrier) to 5 (not important barrier). In addition to these questions, respondents were asked to provide open-ended responses to three questions about barriers and solutions for overcoming barriers. The instructions indicated our interest in problems actually faced at the bedside providing lung-protective ventilation and not in issues related to enrolling patients in or performing the clinical trial. Respondents were asked to report on their entire experience with patients receiving lungprotective ventilation: both in clinical trials and, since many of these centers use low tidal volume ventilation outside of clinical trials, with patients treated outside of clinical trials.
Data Analysis. Barriers were compared based on their mean score coding on an ordinal scale from 1 (very important) to 5 (not important). For categorical analysis, scores of 1 and 2 were coded as "important." Comparison of ordinal data between nurses and respiratory therapists was performed with the rank sum statistic. Comments were coded by the investigators according to the scheme presented. Representative quotations were selected from each of the identified categories of comments.
RESULTS
Surveys were distributed to the research coordinators at each of the ten participating centers in the National Institutes of Health-sponsored ARDS Network. Fifty-five surveys representing all ten sites were received. We received a median of five surveys from each institution (range, one to eight). Eight of the ten sites were able to provide information on the number of surveys distributed, which showed an average response rate of 91%. Twenty-seven (49%) of the respondents were ICU nurses, 24 (44%) were respiratory therapists, and four did not indicate their profession. The median number of patients in whom clinicians estimated they used lung-protective ventilation was 20 (interquartile range, 10 -50).
Based on rankings of the mean barrier score, the most important barriers to initiating lung-protective ventilation were physician unwillingness to relinquish control over mechanical ventilation to a protocol and failure to recognize the patient as having ALI/ARDS ( Table 1) . The most important barriers to continuing lung-protective ventilation were concerns over patient discomfort and tachypnea, concerns over hypercapnia and acidosis, and concerns over declining oxygenation. Forty percent of respondents rated physician unwillingness to relinquish control to a protocol, failure to recognize ALI/ARDS, and perceived contraindications to lung-protective ventilation as important barriers to initiating lung-protective ventilation. Sixty-nine percent of respondents rated concerns over patient comfort, tachypnea, hypercapnia, and acidosis as important barriers to continuing to use lung-protective ventilation. There were no statistically significant differences between rankings of barriers when we compared respiratory therapists to nurses.
Respondents were provided with three areas for open-ended comments. There was a general comments area, an area to enter the "most common error" encountered when trying to provide lungprotective ventilation, and an area to enter advice on overcoming barriers to lung-protective ventilation. After reviewing the comments, we found that seven categories accounted for 91% of the open-ended comments ( Table 2) . Respondents commented most frequently on the importance of sedation and assessment of discomfort. Acidosis and hypercapnia comments included recommendations to teach staff that "just because the [PaCO 2 ] is outside of the normal limits doesn't mean you have to change the vent" and that incorrect perceptions of the risks of mild acidemia prevented many patients from receiving effective lung-protective ventilation. Staff education comments indicated that respondents believed that an understanding of the rationale for and data supporting the benefits of lungprotective ventilation was essential to effective implementation. Respondents indicated that many clinicians understood the concepts behind low tidal volume ventilation but incorrectly calculated tidal volume on the basis of actual or dry weight instead of predicted body weight, leading to inappropriate tidal volumes. Ventilator setup comments were primarily from the respiratory therapists in the study and described pitfalls in setting up mechanical ventilation during lungprotective ventilation including the problems of using low inspiratory flow rates, the failure to measure intrinsic positive end-expiratory pressure, and the observation that overly rapid reductions in tidal volume to achieve the 6 mL/kg predicted body weight goal were associated with acute decompensations in oxygenation. Comments regarding the diagnosis of ALI/ARDS related to the respondents' perceptions of physicians' failure to recognize ALI/ARDS, particularly early in the course of the disease, and use of lungprotective ventilation in patients who did not have lung injury. Finally, respondents commented on aspects of the lungprotective ventilation protocol itself including observations that some clinicians targeted just the static pressure of 30 cm H 2 O or just a target tidal volume rather than starting at 6 mL/kg predicted body weight and titrating the tidal volume to achieve a target static pressure.
DISCUSSION
This study indicates that important barriers will be encountered by clinicians when they try to implement a lungprotective ventilation protocol for patients with ALI/ARDS. Attempts to use lung-protective ventilation will likely be met with significant concerns by ICU nurses and respiratory therapists about the patient's comfort and the safety of hypoxemia, hypercapnia, and acidosis frequently encountered with lung-protective ventilation. In addition, clinicians have difficulty calculating tidal volume on the basis of predicted body weight and using a lung-protective ventilation protocol correctly. The survey respondents believed that physicians failed to recognize ALI/ARDS in all patients who had it, and respondents observed that lung-protective ventilation was used in patients who did not have ALI/ARDS. This observation is consistent with findings by others about confusion regarding the radiographic and hemodynamic criteria for diagnosing ALI/ARDS (14 -17) .
Our data suggest some solutions to overcome these barriers. Respondents believed that extensive education was needed with a focus on the diagnostic criteria for ALI/ARDS, the survival benefits of early initiation of lung-protective ventilation, and the safety of the hypercapnia, mild acidosis, and hypoxemia seen with lung-protective ventilation. Respondents believed that respiratory rate was a primary tool for assessing comfort in mechanically ventilated patients and that this assessment tool was no longer valid in patients receiving lung-protective ventilation who are iatrogenically tachypneic. In this setting, respondents believed that new tools for assessing comfort were necessary. Respondents believed that a written protocol or standing orders facilitated implementation. Finally, respondents believed that avoiding rapid reduction in tidal volumes and increased inspiratory flow rates facilitated the use of lung-protective ventilation.
The emphasis placed on sedation was surprising particularly because the ARDS Network study did not demonstrate increased use of sedation in patients receiving lung-protective ventilation (18) . However, this study only examined sedation use in terms of total days requiring sedation and did not assess drug doses or depth of sedation. Our study suggests that bedside practitioners frequently responsible for assessing and treating agitation and discomfort perceive that lungprotective ventilation requires increased sedation for effective implementation. If patients require increased sedation to tolerate lung-protective ventilation, then clinicians may have to choose between deeper sedation to facilitate lung-protective ventilation and strategies recommending intermittent and lighter levels of sedation in critically ill (2, 19, 20) .
There are several limitations to this study. We intentionally surveyed a group of clinicians experienced with lungprotective ventilation rather than a random sample of hospitals or clinicians because it would be impossible for respondents to comment on barriers to providing a treatment they have never used. This intentional sampling choice imposes important limitations. The survey was designed to sample experienced clinicians from ARDS Network sites and therefore may not represent the barriers other clinicians may encounter. However, we believe that barriers to use of a therapy decline with experience and, therefore, that the bias in this survey is likely toward underestimating the barriers that other centers and clinicians will encounter. Because the sampled sites are teaching hospitals with residents, the observed barriers may not apply to other nonacademic hospitals; however, few of the comments referred specifically to residents. We did not survey physicians because we were interested in the observations of the clinicians who provide this therapy at the bedside. However, this does impose certain limitations on our observations; for example, our data do not address physicians' perceptions of the barriers to providing lung-protective ventilation. Nonphysician peer evaluation of physician practice, and specifically the perceptions and assessments of experienced nurses in the critical care environment, are accepted techniques for evaluating physician practice (21) (22) (23) (24) (25) (26) . Lungprotective ventilation is actually provided in an ongoing fashion by nurses and respiratory therapists; therefore, we believe that their perceptions of the barriers to its use are particularly relevant. It is important to note that this survey can only report the respondents' perceptions of the barriers to implementing lungprotective ventilation. However, understanding these perceptions is crucial to understanding why we do not implement effective practice (5, 8) . Although our goal was to identify experienced nurses and respiratory therapists, it is possible that our respondents shared some other characteristic that might bias their responses; for example, they may have been disgruntled with care at their institutions for other reasons. Finally, this survey does not tell us how often barriers are encountered and what effect these have on actual practice. The goal of this survey was not to detect how often clinicians use lung-protective ventilation. We do not believe that a survey is the best design to evaluate practice, since clinicians' perceptions of their practice and their actual practice often do not agree (27, 28) . This is the first study to explore the barriers clinicians are likely to encounter when they try to implement lungprotective ventilation for ALI/ARDS. Although there are hundreds of cited articles on barriers to implementing guideline-based care from other fields, this study adds to a small body of existing literature on barriers to implementing practice change in critical care (6, 29, 30, 7, 5) . These results are important because they provide insights into how to educate clinicians and design interventions to increase the effective use of lung-protective ventilation. We have shown that there are a number of barriers to implementing lung-protective ventilation as perceived by ICU nurses and respiratory therapists with considerable experience using this therapy. Interventions to increase the use of lung-protective ventilation will need to provide clinicians with tools and practical advice on recognizing ALI/ARDS, implementing lung-protective ventilation, and assessing patients receiving lung-protective ventilation.
Changing clinical behavior is a challenge. Unfortunately, evidence alone has a limited effect on practice. Understanding why clinicians do not use a therapy is essential for designing interventions to increase its use (8, 31, 6) . This study offers clinicians data on which to base educational and quality improvement interventions to increase the use of lungprotective ventilation in patients with ALI/ARDS. 
